• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素A治疗五例重型再生障碍性贫血患儿

Cyclosporine A in five children with severe aplastic anemia.

作者信息

Neira L, Vermylen C, Ninane J, Doyen C, Cornu G

机构信息

Department of Pediatric Hematology and Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

出版信息

Pediatr Hematol Oncol. 1990;7(1):89-98. doi: 10.3109/08880019009034322.

DOI:10.3109/08880019009034322
PMID:2397171
Abstract

Five children with aplastic anemia (AA) were treated with Cyclosporine A (CyA) after failure or poor response to other immunosuppressive agents. A complete remission was achieved in 3 patients, a good partial response in 1, and a poor partial response in another. In 1 patient in whom a complete remission was obtained, a relapse occurred 4 months after CyA was stopped. The treatment was resumed and a complete remission was again observed. Four patients were still on treatment, and side effects were mild. CyA appeared to be an effective treatment in AA.

摘要

5例再生障碍性贫血(AA)患儿在对其他免疫抑制剂治疗无效或反应不佳后接受环孢素A(CyA)治疗。3例患者达到完全缓解,1例有良好的部分缓解,另1例部分缓解效果不佳。在1例获得完全缓解的患者中,停用CyA 4个月后复发。重新开始治疗后再次观察到完全缓解。4例患者仍在接受治疗,副作用较轻。CyA似乎是治疗AA的一种有效方法。

相似文献

1
Cyclosporine A in five children with severe aplastic anemia.环孢素A治疗五例重型再生障碍性贫血患儿
Pediatr Hematol Oncol. 1990;7(1):89-98. doi: 10.3109/08880019009034322.
2
Cyclosporine A treatment in four cases of aplastic anemia.环孢素A治疗4例再生障碍性贫血
Blut. 1987 Feb;54(2):73-8. doi: 10.1007/BF00321033.
3
[Cyclosporin therapy for aplastic anemia].[环孢素治疗再生障碍性贫血]
Rinsho Ketsueki. 1990 Sep;31(9):1450-5.
4
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.使用抗淋巴细胞球蛋白和甲泼尼龙联合或不联合环孢素治疗再生障碍性贫血。德国再生障碍性贫血研究组。
N Engl J Med. 1991 May 9;324(19):1297-304. doi: 10.1056/NEJM199105093241901.
5
[Severe aplastic anemia successfully treated with cyclosporin A and prednisolone].环孢素A和泼尼松龙成功治疗重型再生障碍性贫血
Rinsho Ketsueki. 1989 Dec;30(12):2157-62.
6
Transient expression of trisomy 21 and monosomy 7 following cyclosporin A in a patient with aplastic anemia.一名再生障碍性贫血患者在使用环孢素A后出现21三体和7单体的短暂表达。
Leuk Res. 1991;15(6):531-3. doi: 10.1016/0145-2126(91)90065-2.
7
[Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].[HLA-DRB1*15基因型在儿童获得性再生障碍性贫血中的表达及其与免疫抑制治疗效果的关系]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Dec;15(6):1212-5.
8
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia.
Br J Haematol. 1989 Jun;72(2):278-84. doi: 10.1111/j.1365-2141.1989.tb07695.x.
9
Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.95例接受马抗胸腺细胞球蛋白和环孢素治疗的中度再生障碍性贫血患儿的长期预后
Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26305. Epub 2016 Nov 3.
10
Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia.环孢素A在严重再生障碍性贫血异基因骨髓移植中的应用。
Transplantation. 1982 Apr;33(4):382-6. doi: 10.1097/00007890-198204000-00008.

引用本文的文献

1
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.环孢素。对其药效学和药代动力学特性以及在免疫调节紊乱中的治疗应用的综述。
Drugs. 1993 Jun;45(6):953-1040. doi: 10.2165/00003495-199345060-00007.